This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Marla Wohlman; Robert Allaben, MD; James Whitten, MD; Georgeann Edford, RN; Sidney Baskin, MD; Lawrence McNichol, MD; Luis H. Toledo-Perevra, MD, PhD
Mt Carmel Mercy Hospital Detroit

JAMA. 1981;245(24):2493-2494.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

Corticosteroids are part of the basic immunosuppressive regimen despite the number of metabolic and infectious complications associated with their prolonged use. It has long been considered that administration of twice the normal daily dose of prednisone on alternate days could minimize harmful side effects without precipitating rejection episodes in renal transplant patients.^1,2 Hypoadrenalism¹ and increased rejection rates³ preclude alternate-day (AD) therapy in some patients. However, it is frequently used in treating children⁴ because of its decreased effect on growth suppression.

Recent publications indicate decreased side effects in patients on AD prednisone administration. Results are particularly favorable in patients who were previously treated with relatively high daily doses.⁵ In addition, results do not seem to differ between patient populations receiving living-related or cadaver kidneys.

In most reports, assessment of renal function is based on the comparison of averaged creatinine clearance (GFR) or serum creatinine . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?